TNDM Tandem Diabetes Care


Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

ESG term mentions

In last year of SEC filings
AirEcosystemEnvironmentEnvironmentalExtractionLandfillMaterialsNatural ResourcesNatureOffsetPackagePackagingPandemicPlasticPollutionRaw MaterialsRecyclingWasteWaterAccessAffordabilityBenefitsBlackCalifornia Consumer Privacy ActCharitableCollective BargainingCommunityCultureCustomerCustomer SatisfactionCyberCybersecurityData PrivacyData SecurityDeathDisabilityDiversityDiversity and InclusionEmployeeEngagementEthnicEthnicityGenderGeneral Data Protection RegulationHealth and SafetyHealth CareHealthcareHireHiringHuman CapitalHuman ResourcesIncidentInjuriesInjuryPay for PerformancePrivacyProduct QualityProduct SafetyRecallRecruitRecruitmentReimbursementRetentionRetirementSafetySatisfactionSkillSkillsSocialStakeholderSupplierSupply ChainTalentTrainingUnionVolunteerWomenWorkforceAction PlanAnti-corruptionAssessmentAssuranceAuditBoard OversightBonusBribeBriberyChronicClass Action LawsuitClassifiedClawbackCommitmentConflict of InterestCorporate GovernanceCorporate PurposeDepartment ofESGEthicsExecutive CompensationExpertFraudGoalsGovernanceHedgingIncentiveIncentivizeIndependenceIndependentInnovateInnovationInnovativeInvestigationKey Performance IndicatorLawsuitLead Independent DirectorLeadershipLitigationLong-termMajorityMissionOverseeOversightPlaintiffPledgingProcurementProxy ContestPurposeQuality StandardR&DReputationReputationalReputational RiskResearch and DevelopmentResponsibilityResponsibleStockholder EngagementStockholder OutreachStrategySustainabilitySustainableTargetsTaxTax Gross UpTenureTransparentVoting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On May 18, 2021, Tandem Diabetes Care, Inc. (the “Company”) held a virtual Annual Meeting of Stockholders (the “Annual Meeting”). There were 62,555,485 shares of the Company’s common stock (“Common Stock”) outstanding on March 23, 2021, the record date for the Annual Meeting. At the Annual Meeting, 55,473,103 shares of Common Stock were present virtually or represented by proxy.

The following tables set forth the final results of the voting for the matters voted upon at the Annual Meeting. These matters are described in more detail in the Company’s definitive proxy statement, filed with the Securities and Exchange Commission (the "SEC") on April 7, 2021 (the “Proxy Statement”).

Proposal 1: The election of three Class II directors to serve a three-year term to expire at the 2024 annual meeting of stockholders. The stockholders elected the three Class II directors by the following votes:

Name of DirectorForAgainstAbstainBroker Non-Votes
Dick P. Allen41,972,5997,715,67033,7185,751,116
Rebecca B. Robertson48,918,233771,44832,3065,751,116
Rajwant S. Sodhi49,410,769275,66635,5525,751,116

Proposal 2: The ratification of the appointment of Ernst & Young LLP to serve as the Company's independent registered public accountant for the year ending December 31, 2021. The proposal received the following votes:

ForAgainstAbstainBroker Non-Votes

Proposal 3: To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as described in the Proxy Statement. The proposal received the following votes:

ForAgainstAbstainBroker Non-Votes